StockData
Bicara Therapeutics Inc. logo

Bicara Therapeutics Inc. (BCAX) stock

BCAXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30
$9.60−0.15 (-1.54%)

Close on Nov 17, 2026Market cap $635.26MP/E –Yield –

Bicara Therapeutics total assets

Total assets on the balance sheet at the end of each period.

Bicara Therapeutics's total assets was $460.64M at Sep 30, 2026. For fiscal 2025 it was $430.99M, down 15.5% from the year before.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$430.99M-15.5%
FY2024Dec 31, 2024$510.00M+118.0%
FY2023Dec 31, 2023$233.98M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$460.64M+8.5%
Q2 FY2026Jun 30, 2026$512.24M+12.9%
Q1 FY2026Mar 31, 2026$553.60M+15.8%
Q4 FY2025Dec 31, 2025$430.99M-15.5%
Q3 FY2025Sep 30, 2025$424.69M-19.0%
Q2 FY2025Jun 30, 2025$453.59M+93.9%
Q1 FY2025Mar 31, 2025$478.08M–
Q4 FY2024Dec 31, 2024$510.00M–
Q3 FY2024Sep 30, 2024$524.17M–
Q4 FY2023Dec 31, 2023$233.98M–

More Bicara Therapeutics figures

See a number that looks wrong?